Guhaprasad Nagarajan has taken over as the Chief Executive Officer (CEO) of Aculife Healthcare Pvt Ltd, a Nirma Group company. Aculife is a leader in intravenous fluids manufacturing with a product portfolio comprising of electrolytes, blood products, plasma volume expanders, specialised solutions like anaesthetics, parenteral nutrition and specialised antibiotics.
The $100 million company has eight manufacturing plants and employs over 4,000 employees with a presence in over 70 countries.
As the CEO of Aculife, Guhaprasad will institutionalise best practices into the entire value chain from product development to achieving leadership position in the markets that the company has its presence in. He also intends to leverage the organisation’s excellent manufacturing infrastructure to penetrate into newer specialised portfolios.
Guhaprasad comes with a varied experience of over 30 years in building brands and teams by institutionalising the brand, sales and team practices for reputed pharmaceutical companies in the global markets including India.
He has been credited with spearheading the presence of Alkem Laboratories in the high end antibiotics markets; Ipca Laboratories in Cardiovascular and Antidiabetic markets, and also successfully building its Global Brands and Global Institutional business in over 40 countries.
Aculife, a part of the Nirma group of companies, has the world’s largest manufacturing infrastructure spread over 650 acres for parenteral solutions under one roof.
An alumnus of UDCT Mumbai, Guhaprasad is a B.Sc. Tech with a Masters in Management Studies (MMS) in Marketing from Somaiya Institute of Management and Research, Mumbai.
He has served in various capacities at some of the country’s top pharma organisations including Wockhardt, Alkem Laboratories and IPCA Laboratories.